Literature DB >> 16956297

Investigation of the catalytic mechanism of farnesyl pyrophosphate synthase by computer simulation.

Verónica Muriel Sanchez1, Alejandro Crespo, J Silvio Gutkind, Adrián Gustavo Turjanski.   

Abstract

Farnesyl pyrophosphate synthase (FPPS) catalyses the formation of a key cellular intermediate in isoprenoid metabolic pathways, farnesyl pyrophosphate, by the sequential head-to-tail condensation of two molecules of isopentenyl diphosphate (IPP) with dimethylallyl diphosphate (DMAPP). Recently, FPPS has been shown to represent an important target for the treatment of parasitic diseases such as Chagas disease and African trypanosomiasis. Bisphosphonates, pyrophosphate analogues in which the oxygen bridge between the two phosphorus atoms has been replaced by a carbon substituted with different side chains, are able to inhibit the FPPS enzyme. Moreover, nitrogen-containing bisphosphonates have been proposed as carbocation transition state analogues of FPPS. On the basis of structural and kinetic data, different catalytic mechanisms have been proposed for FPPS. By analyzing different reaction coordinates we propose that the reaction occurs in one step through a carbocationic transition state and the subsequent transfer of a hydrogen atom from IPP to the pyrophosphate moiety of DMAPP. Moreover, we have analyzed the role of the active site amino acids on the activation barrier and the reaction mechanism. The structure of the active site is well conserved in the isoprenyl diphosphate synthase family; thus, our results are relevant for the understanding of this important class of enzymes and for the design of more potent and specific inhibitors for the treatment of parasitic diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16956297     DOI: 10.1021/jp063099q

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  8 in total

1.  In silico and in vitro analyses identified three amino acid residues critical to the catalysis of two aphid farnesyl diphosphate synthase.

Authors:  Xiao-Fang Sun; Zheng-Xi Li
Journal:  Protein J       Date:  2012-06       Impact factor: 2.371

2.  Identification of a lysine residue important for the catalytic activity of yeast farnesyl diphosphate synthase.

Authors:  Marc J C Fischer; Sophie Meyer; Patricia Claudel; Marc Bergdoll; Francis Karst
Journal:  Protein J       Date:  2011-06       Impact factor: 2.371

3.  Mechanistic insights into protonation state as a critical factor in hFPPS enzyme inhibition.

Authors:  David Fernández; Joaquin Ortega-Castro; Laura Mariño; Joan Perelló; Juan Frau
Journal:  J Comput Aided Mol Des       Date:  2015-06-17       Impact factor: 3.686

4.  How mitogen-activated protein kinases recognize and phosphorylate their targets: A QM/MM study.

Authors:  Adrian Gustavo Turjanski; Gerhard Hummer; J Silvio Gutkind
Journal:  J Am Chem Soc       Date:  2009-05-06       Impact factor: 15.419

5.  Ternary complex structures of human farnesyl pyrophosphate synthase bound with a novel inhibitor and secondary ligands provide insights into the molecular details of the enzyme's active site closure.

Authors:  Jaeok Park; Yih-Shyan Lin; Joris W De Schutter; Youla S Tsantrizos; Albert M Berghuis
Journal:  BMC Struct Biol       Date:  2012-12-12

6.  Biochemical evidence for the tyrosine involvement in cationic intermediate stabilization in mouse beta-carotene 15, 15'-monooxygenase.

Authors:  Eugenia Poliakov; Susan Gentleman; Preethi Chander; Francis X Cunningham; Bella L Grigorenko; Alexander V Nemuhin; T Michael Redmond
Journal:  BMC Biochem       Date:  2009-12-14       Impact factor: 4.059

7.  Cloning and characterization of bifunctional enzyme farnesyl diphosphate/geranylgeranyl diphosphate synthase from Plasmodium falciparum.

Authors:  Fabiana M Jordão; Heloisa B Gabriel; João M P Alves; Claudia B Angeli; Thaís D Bifano; Ardala Breda; Mauro F de Azevedo; Luiz A Basso; Gerhard Wunderlich; Emilia A Kimura; Alejandro M Katzin
Journal:  Malar J       Date:  2013-06-04       Impact factor: 2.979

8.  The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants.

Authors:  Maria K Tsoumpra; Joao R Muniz; Bobby L Barnett; Aaron A Kwaasi; Ewa S Pilka; Kathryn L Kavanagh; Artem Evdokimov; Richard L Walter; Frank Von Delft; Frank H Ebetino; Udo Oppermann; R Graham G Russell; James E Dunford
Journal:  Bone       Date:  2015-08-28       Impact factor: 4.398

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.